Optimizing Raw Material Strategies for Robust & Scalable mRNA Manufacturing

  • Examining how differences in input components influence yield, consistency, and impurity profiles across mRNA manufacturing workflows
  • Establishing control strategies to ensure consistency without restricting flexibility- defining specifications, sourcing approaches, and risk-based frameworks that maintain quality while supporting process optimization and platform development
  • Embedding raw material considerations into next-generation platform design – ensuring approaches are adaptable across emerging modalities while enabling faster development timelines, improved robustness, and reduced cost of goods